1. A Novel Biosynthesized ZnFe2O4@Ag Nanocomposite: Implications for Cytotoxicity, Gene Expression and Antiproliferative Studies in Breast Cancer Cell Line
   Shadi Jodati et al, 2023, Journal of Cluster Science CrossRef
2. Insights into the involvement of long non-coding RNAs in doxorubicin resistance of cancer
   Hai-Bo Zhang et al, 2023, Frontiers in Pharmacology CrossRef
3. Long Non-Coding RNA Cancer Susceptibility Candidate 9 Regulates the Malignant Biological Behavior of Nasopharyngeal Carcinoma Cells by Targeting miR-497-5p/Wnt3a/β-catenin Signaling Pathway
   Yue Lei et al, 2022, Frontiers in Oncology CrossRef
4. Coding roles of long non-coding RNAs in breast cancer: Emerging molecular diagnostic biomarkers and potential therapeutic targets with special reference to chemotherapy resistance
   Dharambir Kashyap et al, 2023, Frontiers in Genetics CrossRef
5. ABCC6P1 pseudogene induces ABCC6 upregulation and multidrug resistance in breast cancer
   Mahnaz Hashemi et al, 2022, Molecular Biology Reports CrossRef
6. Exploiting Therapeutic Vulnerabilities in Triple-Negative Breast Cancer: Successes, Challenges, and Opportunities
   Margarite Matossian et al, 2023, Current Breast Cancer Reports CrossRef
7. Propofol suppresses proliferation, migration, invasion, and tumor growth of liver cancer cells via suppressing cancer susceptibility candidate 9/phosphatase and tensin homolog/AKT serine/threonine kinase/mechanistic target of rapamycin kinase axis
   Qing Chang et al, 2022, Human & Experimental Toxicology CrossRef
8. Oncogenic LncRNA CASC9 in Cancer Progression
   Yuying Qi et al, 2021, Current Pharmaceutical Design CrossRef